Ming Yan - Mar 7, 2022 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
Chief Technology Officer, Director
Signature
/s/ Valerie Barnett, Attorney-in-Fact for Ming Yan
Stock symbol
CTKB
Transactions as of
Mar 7, 2022
Transactions value $
$25,325
Form type
4
Date filed
3/8/2022, 04:57 PM
Previous filing
Mar 2, 2022
Next filing
Mar 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTKB Common Stock Options Exercise $15.6K +62.5K +0.77% $0.25* 8.15M Mar 7, 2022 Direct
transaction CTKB Common Stock Options Exercise $9.71K +10.6K +0.13% $0.92* 8.16M Mar 7, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTKB Stock Option (Right to Buy) Options Exercise $0 -62.5K -100% $0.00* 0 Mar 7, 2022 Common Stock 62.5K $0.25 Direct
transaction CTKB Stock Option (Right to Buy) Options Exercise $0 -10.6K -39.58% $0.00 16.1K Mar 7, 2022 Common Stock 10.6K $0.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest as follows: 25% of the shares subject to the option vests on July 24, 2021; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years.